Bob Nordyke is VP of Research and brings extensive project and organizational leadership, health economics, and health policy experience to NPC. Over the last 20 years, Bob has held roles of increasing impact in health economics consulting and in the pharmaceutical industry. He has founded several health economics consulting practices including Beta6 Consulting Group, PriceSpective, and with Precision Medicine Group. In industry, Bob was VP and Head of Health Economics and Access at Angion Biomedica and previously was a therapeutic area head at Amgen Global Health Economics.
Dr. Nordyke has also served in senior advisory roles nationally, most recently on the steering committee for two projects under the ASN/FDA Kidney Health Initiative. He has been a lecturer at the USC Sol Price School of Public Policy and an adjunct professor at the UCLA Fielding School of Public Health. Bob received his BS in engineering from Rose-Hulman Institute of Technology, an MS in engineering from the University of Texas-Austin, and a PhD in Public Policy Analysis from the Pardee RAND Graduate School.